Publicaciones en las que colabora con JOSÉ JAVIER FERNÁNDEZ RUIZ (19)

2014

  1. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

2013

  1. Description of a bivalent cannabinoid ligand with hypophagic properties

    Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179

  2. Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1708-1716

1996

  1. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats

    Behavioural Brain Research, Vol. 75, Núm. 1-2, pp. 91-98

1994

  1. Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement

    Life Sciences, Vol. 54, Núm. 3, pp. 159-170

  2. Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment

    Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 33-40

  3. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids

    Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 47-58

1993

  1. Acute effects of ∆<sup>9</sup>-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle

    Neuroendocrinology, Vol. 58, Núm. 3, pp. 280-286

  2. Presence of cannabinoid binding sites in the brain from early postnatal ages

    NeuroReport, Vol. 4, Núm. 2, pp. 135-138

  3. δ9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens

    Journal of Neural Transmission, Vol. 92, Núm. 2-3, pp. 81-95

1992

  1. Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

    Pharmacology, Biochemistry and Behavior, Vol. 42, Núm. 2, pp. 269-275

  2. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids

    Pharmacology, Biochemistry and Behavior, Vol. 41, Núm. 3, pp. 469-474

  3. Estrogenic modulation of δ9-Tetrahydrocannabinol effects on nigrostriatal dopaminergic activity in the female rat brain

    Molecular and Cellular Neuroscience, Vol. 3, Núm. 4, pp. 315-325

  4. Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice

    Pharmacology, Biochemistry and Behavior, Vol. 43, Núm. 2, pp. 603-608

1991

  1. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments

    Pharmacology, Biochemistry and Behavior, Vol. 40, Núm. 3, pp. 593-598

  2. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons

    Neuroscience, Vol. 43, Núm. 2-3, pp. 713-723

  3. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels

    Life Sciences, Vol. 48, Núm. 6, pp. 531-541

  4. Prolonged effects of persistent hyperprolactinemia on adrenal medullary function in male rats

    Biogenic Amines, Vol. 8, Núm. 1, pp. 69-75

1990

  1. Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats

    Developmental Brain Research, Vol. 51, Núm. 2, pp. 237-240